Insider · CIK 0002021704
Ronald Totton
Files at KORE (KORE Group Holdings, Inc.). First filing Aug 18, 2025, latest Aug 18, 2025.
In brief
Ronald Totton files SEC Form 4 as CEO, president and director at KORE (KORE Group Holdings, Inc.). Since Aug 18, 2025, Ronald Totton has reported 0 open-market buys worth $0 and 1 open-market sell worth $12k, the latest filed on Aug 18, 2025.
A track record needs three past buys with six months of prices behind them; Ronald Totton has 0, so none is measured yet.
The newest scored trade: sold $12k of KORE on Aug 14, 2025, filed Aug 18, 2025, scored 10 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | KOREsell KORE Group Holdings, Inc. | $12k 5,016 shares | -10% | - |
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | KORE KORE Group Holdings, Inc. | DDisposition to issuer Common Stock | -92,036 | $9.25 | $851k | 0 | Jul 23, 2026 |
| Jul 21, 2026 | KORE KORE Group Holdings, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -75,000 | $9.25 | $694k | 0 | Jul 23, 2026 |
| Jun 30, 2026 | KORE KORE Group Holdings, Inc. | MOption exercise Common Stock | +40,000 | $0.00 | $0 | 86,601 | Jul 2, 2026 |
| Jun 30, 2026 | KORE KORE Group Holdings, Inc. | FTax withholding Common Stock | -12,040 | $9.23 | $111k | 74,561 | Jul 2, 2026 |
| Jun 30, 2026 | KORE KORE Group Holdings, Inc. | MOption exercise Common Stock | +25,000 | $0.00 | $0 | 99,561 | Jul 2, 2026 |
| Jun 30, 2026 | KORE KORE Group Holdings, Inc. | FTax withholding Common Stock | -7,525 | $9.23 | $69k | 92,036 | Jul 2, 2026 |
| Jun 30, 2026 | KORE KORE Group Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -40,000 | $0.00 | $0 | 0 | Jul 2, 2026 |
| Jun 30, 2026 | KORE KORE Group Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -25,000 | $0.00 | $0 | 75,000 | Jul 2, 2026 |
| Aug 14, 2025 | KORE KORE Group Holdings, Inc. | MOption exercise Common Stock | +16,667 | $0.00 | $0 | 51,617 | Aug 18, 2025 |
| Aug 14, 2025 | KORE KORE Group Holdings, Inc. | SOpen-market sale Common Stock | -5,016 | $2.43 | $12k | 46,601 | Aug 18, 2025 |
| Aug 14, 2025 | KORE KORE Group Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -16,667 | $0.00 | $0 | 183,333 | Aug 18, 2025 |
| Jun 30, 2025 | KORE KORE Group Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +40,000 | $0.00 | $0 | 40,000 | Jul 2, 2025 |
| Jun 30, 2025 | KORE KORE Group Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +100,000 | $0.00 | $0 | 100,000 | Jul 2, 2025 |
| Apr 29, 2025 | KORE KORE Group Holdings, Inc. | MOption exercise Common Stock | +50,000 | $0.00 | $0 | 50,000 | May 1, 2025 |
| Apr 29, 2025 | KORE KORE Group Holdings, Inc. | FTax withholding Common Stock | -15,050 | $2.47 | $37k | 34,950 | May 1, 2025 |
| Apr 29, 2025 | KORE KORE Group Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -50,000 | $0.00 | $0 | 0 | May 1, 2025 |
Questions about Ronald Totton
Answered from the filings on this page, as of the latest one.
Is Ronald Totton buying or selling?
Not in the last 12 months. Ronald Totton's latest open-market trade on SEC Form 4 was sold $12k of KORE on Aug 14, 2025.
How did Ronald Totton's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ronald Totton has 0.
Where does Ronald Totton file Form 4?
Ronald Totton has filed Form 4 at KORE (KORE Group Holdings, Inc.) as President & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.